Pesquisa | Secretaria de Estado da Saúde

1.

Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.

Vitug, Christian; Lajkosz, Katherine; Chavarriaga, Julian; Llano, Andres; Din, Shayan; Villegas, Eunice; Kuk, Cynthia; Chan, Amy; Gao, Bruce; Hemminki, Otto; Kot, Dhiral; Misurka, Jimmy; van der Kwast, Theodorus H; Wallis, Christopher; Jewett, Michael A S; Soloway, Mark S; Fleshner, Neil E; Kulkarni, Girish S; Zlotta, Alexandre R.

BJU Int ; 133(3): 289-296, 2024 Mar.

Artigo Inglês | MEDLINE | ID: mdl-38105525

2.

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.

Wang, Jiaojiao; Jordan, Andre R; Zhu, Huabin; Hasanali, Sarrah L; Thomas, Eric; Lokeshwar, Soum D; Morera, Daley S; Alexander, Sung; McDaniels, Joseph; Sharma, Anuj; Aguilar, Karina; Sarcan, Semih; Zhu, Tianyi; Soloway, Mark S; Terris, Martha K; Thangaraju, Muthusamy; Lopez, Luis E; Lokeshwar, Vinata B.

Cancer Cell Int ; 22(1): 421, 2022 Dec 29.

Artigo Inglês | MEDLINE | ID: mdl-36581895

3.

Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.

Morera, Daley S; Hasanali, Sarrah L; Belew, Daniel; Ghosh, Santu; Klaassen, Zachary; Jordan, Andre R; Wang, Jiaojiao; Terris, Martha K; Bollag, Roni J; Merseburger, Axel S; Stenzl, Arnulf; Soloway, Mark S; Lokeshwar, Vinata B.

J Urol ; 203(1): 62-72, 2020 01.

Artigo Inglês | MEDLINE | ID: mdl-31112107

4.

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.

Fernández, Mario I; Brausi, Maurizio; Clark, Peter E; Cookson, Michael S; Grossman, H Barton; Khochikar, Makarand; Kiemeney, Lambertus A; Malavaud, Bernard; Sanchez-Salas, Rafael; Soloway, Mark S; Svatek, Robert S; Vikram, Raghunandan; Vrieling, Alina; Kamat, Ashish M.

World J Urol ; 37(1): 3-13, 2019 Jan.

Artigo Inglês | MEDLINE | ID: mdl-30105454

5.

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.

Morera, Daley S; Hennig, Martin S; Talukder, Asif; Lokeshwar, Soum D; Wang, Jiaojiao; Garcia-Roig, Michael; Ortiz, Nicolas; Yates, Travis J; Lopez, Luis E; Kallifatidis, Georgios; Kramer, Mario W; Jordan, Andre R; Merseburger, Axel S; Manoharan, Murugesan; Soloway, Mark S; Terris, Martha K; Lokeshwar, Vinata B.

Br J Cancer ; 117(10): 1507-1517, 2017 Nov 07.

Artigo Inglês | MEDLINE | ID: mdl-28972965

6.

Ct2 Bladder Cancer.

Soloway, Mark S.

Curr Urol Rep ; 17(9): 66, 2016 Sep.

Artigo Inglês | MEDLINE | ID: mdl-27457483

7.

Nocturia.

Soloway, Mark S; Weiss, Jeffrey P; Wein, Alan J.

Curr Urol Rep ; 17(10): 77, 2016 Oct.

Artigo Inglês | MEDLINE | ID: mdl-27595997

8.

Challenging Case: Stones.

Soloway, Mark S; Ziemba, Justin B; Matlaga, Brian R; Monga, Manoj.

Curr Urol Rep ; 17(10): 75, 2016 Oct.

Artigo Inglês | MEDLINE | ID: mdl-27566646

9.

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Amin, Mahul B; Smith, Steven C; Reuter, Victor E; Epstein, Jonathan I; Grignon, David J; Hansel, Donna E; Lin, Oscar; McKenney, Jesse K; Montironi, Rodolfo; Paner, Gladell P; Al-Ahmadie, Hikmat A; Algaba, Ferran; Ali, Syed; Alvarado-Cabrero, Isabel; Bubendorf, Lukas; Cheng, Liang; Cheville, John C; Kristiansen, Glen; Cote, Richard J; Delahunt, Brett; Eble, John N; Genega, Elizabeth M; Gulmann, Christian; Hartmann, Arndt; Langner, Cord; Lopez-Beltran, Antonio; Magi-Galluzzi, Cristina; Merce, Jorda; Netto, George J; Oliva, Esther; Rao, Priya; Ro, Jae Y; Srigley, John R; Tickoo, Satish K; Tsuzuki, Toyonori; Umar, Saleem A; Van der Kwast, Theo; Young, Robert H; Soloway, Mark S.

Mod Pathol ; 28(5): 612-30, 2015 May.

Artigo Inglês | MEDLINE | ID: mdl-25412849

10.

Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Lokeshwar, Soum D; Ruiz-Cordero, Roberto; Hupe, Marie C; Jorda, Merce; Soloway, Mark S.

World J Urol ; 33(12): 1929-36, 2015 Dec.

Artigo Inglês | MEDLINE | ID: mdl-25833661

11.

Expectant Management of Low-Risk Bladder Cancer.

Smith, Zachary L; Soloway, Mark S.

Curr Urol Rep ; 16(12): 82, 2015 Dec.

Artigo Inglês | MEDLINE | ID: mdl-26486930

12.

Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Mansour, Ahmed M; Soloway, Mark S; Eldefrawy, Ahmed; Singal, Rakesh; Joshi, Shivam; Manoharan, Murugesan.

Can J Urol ; 22(2): 7690-7, 2015 Apr.

Artigo Inglês | MEDLINE | ID: mdl-25891331

13.

Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper.

Culkin, Daniel J; Exaire, Emilio J; Green, David; Soloway, Mark S; Gross, Andreas J; Desai, Maheshbhai R; White, James R; Lightner, Deborah J.

J Urol ; 192(4): 1026-34, 2014 Oct.

Artigo Inglês | MEDLINE | ID: mdl-24859439

14.

Differential expression of SDF-1 isoforms in bladder cancer.

Gosalbez, Miguel; Hupe, Marie C; Lokeshwar, Soum D; Yates, Travis J; Shields, John; Veerapen, Muthu K; Merseburger, Axel S; Rosser, Charles J; Soloway, Mark S; Lokeshwar, Vinata B.

J Urol ; 191(6): 1899-1905, 2014 Jun.

Artigo Inglês | MEDLINE | ID: mdl-24291546

15.

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

Truong, Matthew; Slezak, Jon A; Lin, Chee Paul; Iremashvili, Viacheslav; Sado, Martins; Razmaria, Aria A; Leverson, Glen; Soloway, Mark S; Eggener, Scott E; Abel, E Jason; Downs, Tracy M; Jarrard, David F.

Cancer ; 119(22): 3992-4002, 2013 Nov 15.

Artigo Inglês | MEDLINE | ID: mdl-24006289

16.

Editorial Comment.

Soloway, Mark S.

J Urol ; 199(2): 406, 2018 02.

Artigo Inglês | MEDLINE | ID: mdl-29097189

17.

Active Surveillance or Office Fulguration for Low Grade Ta Bladder Tumors: A Win-Win for Patients and Urologists.

Soloway, Mark S.

J Urol ; 199(5): 1120-1122, 2018 05.

Artigo Inglês | MEDLINE | ID: mdl-28987859

18.

Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods.

Iremashvili, Viacheslav; Lokeshwar, Soum D; Jorda, Merce; Pelaez, Liset; Soloway, Mark S.

J Urol ; 190(1): 84-90, 2013 Jul.

Artigo Inglês | MEDLINE | ID: mdl-23246479

19.

A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Eggener, Scott E; Mueller, Alex; Berglund, Ryan K; Ayyathurai, Raj; Soloway, Cindy; Soloway, Mark S; Abouassaly, Robert; Klein, Eric A; Jones, Steven J; Zappavigna, Chris; Goldenberg, Larry; Scardino, Peter T; Eastham, James A; Guillonneau, Bertrand.

J Urol ; 189(1 Suppl): S19-25; discussion S25, 2013 Jan.

Artigo Inglês | MEDLINE | ID: mdl-23234624

20.

Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?

Soloway, Mark S.

BJU Int ; 122(4): 525-526, 2018 10.

Artigo Inglês | MEDLINE | ID: mdl-30251474

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Sua seleção (0)

Formato de exportação:

Exportar:

Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.

Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.

Ct2 Bladder Cancer.

Nocturia.

Challenging Case: Stones.

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Expectant Management of Low-Risk Bladder Cancer.

Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper.

Differential expression of SDF-1 isoforms in bladder cancer.

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

Editorial Comment.

Active Surveillance or Office Fulguration for Low Grade Ta Bladder Tumors: A Win-Win for Patients and Urologists.

Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods.

A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?